LEI 6488Z7WG18Q0ZN0V0262
PILA PHARMA AB
Contract awards & public grants
PILA PHARMA AB — Vinnova funding
Vinnova · SE · Grant · 2026-01-01
SEK 25,000
PILA PHARMA AB — Vinnova funding
Vinnova · SE · Grant · 2024-01-01
SEK 15,000
Clinical assessment of PILA PHARMA’s TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent → PILA PHARMA AB
European Commission · SE · Grant · 2019-01-23
€50,000
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.